Navigation Links
CryoLife Names Philip Theodore as Vice President, General Counsel
Date:9/4/2007

ATLANTA, Sept. 4 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, announced today that Philip A. Theodore has been named vice president, general counsel, effective September 4, 2007. Mr. Theodore will report directly to Steven G. Anderson, chairman, president and chief executive officer of the Company.

As general counsel, Mr. Theodore will be responsible for all corporate legal and governance activities, and will be involved in the execution of the Company's strategic growth plan, including acquisitions and other external transactions.

"We are delighted that Phil has joined our corporate leadership team at Cryolife," said Steve Anderson. "His extensive experience in the life sciences industry, and in mergers, acquisitions and other transactions, will be key as the Company continues to grow its business and leverage its strengths in its core marketplaces."

Mr. Theodore gained his life sciences expertise while serving as vice president, general counsel and corporate secretary of Serologicals Corporation, a global provider of biological products, enabling technologies and services, from January 2004 through July 2006, when Serologicals was acquired by a competitor. Most recently, Mr. Theodore was senior vice president and general counsel of John H. Harland Company, a New York Stock Exchange traded company that was acquired by a competitor on May 1, 2007. Mr. Theodore practiced law in the Atlanta office of King & Spalding, LLP for 22 years, representing both buyers and sellers in mergers, acquisitions and other transactions, including various financing transactions. He joined King & Spalding LLP in 1981, becoming partner in 1986.

About CryoLife, Inc.

Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the United States and Canada. The Company's BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. The Company also distributes the CryoLife-O'Brien(R) stentless porcine heart valve and the SG Model 100 vascular graft, which are CE marked for distribution within the European Community.

For additional information about the company, visit CryoLife's Web site: http://www.cryolife.com

CryoLife Media Contacts:

D. Ashley Lee

Executive Vice President, Chief Operating Officer and

Chief Financial Officer

CryoLife, Inc.

Phone: 770-419-3355

Katie Brazel

Fleishman-Hillard

Phone: 404-739-0150


'/>"/>
SOURCE CryoLife, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Wisconsin IT association names Gee president, CEO
2. Quintessence Biosciences names new president
3. CDW names VP to handle Berbee merger
4. NimbleGen names CFO with capital-raising past
5. Cisco names Berbee a top partner of 2005
6. Cisco names Inacom most innovative partner
7. UW-Madison medical school names new dean
8. GE Healthcare names new CEO
9. Bruker AXS names new leadership
10. Sonic Foundry names new senior vice president
11. MyWeather names new president, marketing officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... LOS ANGELES , Feb. 21, 2017  Lexus, a returning ... its role as the official and exclusive automobile partner of the ... annual spring race. The 2017 Amgen Tour of ... five-year commitment and feature some of the best professional cycling teams ... , May 14-20. The four-day Amgen Breakaway from Heart ...
(Date:2/20/2017)... ... February 20, 2017 , ... Global relationship marketing ... approved for full, active membership in the Canadian Direct Sellers Association (DSA) effective ... Executive Officer Jeff Olson in 2011. Today Nerium International, with its ...
(Date:2/20/2017)... ... February 20, 2017 , ... Cancer diagnostics ... Insight: Oncology™” (Crosswalk), a unique precision medicine knowledge visualization and decision support platform. ... through Inspirata’s diagnostic cockpit and is downloadable as an app for any mobile ...
(Date:2/20/2017)... 20, 2017  At the 2017 Health Information ... Orlando , IBM (NYSE: IBM ) ... IBM Chairman, President and CEO Ginni Rometty ... today from 8:30-10 am ET, broadcast live on ... Her remarks examine the advent of the Cognitive ...
Breaking Biology Technology:
(Date:2/2/2017)...  Central to its deep commitment to honor ... Japan Prize Foundation today announced the laureates of ... envelope in their respective fields of Life Sciences ... being recognized with the 2017 Japan Prize for ... to the advancement of science and technology, but ...
(Date:1/30/2017)... 30, 2017   Invitae Corporation (NYSE: ... information companies, today announced that it will report its ... 2017 guidance on Monday, February 13, 2017, and Invitae,s ... at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... briefly review financial results, guidance, and recent developments and ...
(Date:1/25/2017)... 2017 The Elements of Enterprise Information Security ... comprised of a comprehensive set of business processes ... digital identities and providing a secured and documented ... significant number of programs opted by enterprises to ... optimizing processes and changing policies. However, there are ...
Breaking Biology News(10 mins):